Induced Pluripotent Stem Cells: A Powerful Tool for Drug Discovery & Safety Screening

 Stevenage Bio Event

Professor Lyle Armstrong will be attending a special event on Wednesday 24th October at the Stevenage Bioscience Catalyst where he will give an innovative presentation on ‘Induced Pluripotent Stem Cells: A Powerful Tool For Drug Discovery & Safety Screening’.

Professor Armstrong studied chemistry at the Universities of Sheffield and Northumbria and was awarded a PhD in physical organic chemistry in 1992. As an outcome of his PhD research into the chemistry of fluorescent molecules, he founded a contract research organisation developing and licensing diagnostic systems to identify and enumerate bacteria in biological fluids. This organisation was successful in generating a range of products that were subsequently licensed to industry and marketed as microbial diagnostic tools. Prof Armstrong’s highly respected research group is focussed on reprogramming cells to hiPSCs and developing organoid and other complex models of human tissues. A key aspect of this investigation is researching the possible reversal of ageing during the reprogramming process and how this might be valuable for repairing organ damage or treating human diseases using induced pluripotent stem cells.


12:00 – Networking Lunch
12:25 – Welcome From Miranda
12:30 – Presentations Plus Q&A
13:30 – Warm Up

For more information regarding this event please contact the Stevenage Bioscience Catalyst directly by emailing
Stevenage Bioscience Catalyst
You might also be interested in…

Looking Forward: A Year in Review

2018 has been a significant year for Newcells Biotech. We have secured substantial investment, launched new, ground-breaking products, attended global events and expanded our every growing team.   Here are some of our defining moments


Newcells Head to Boston

International Trade Mission – December 2018  Newcells Biotech CEO, Dr Mike Nicholds, and CSO, Prof Lyle Armstrong, are delighted to be taking part in a global trade mission hosted by the Department for International Trade and partially funded by the Northern Powerhouse. Dr Nicholds and Prof Armstrong will travel to Greater


ESTIV 2018 International Congress

Congress Round-Up The International Congress on in vitro Toxicology (ESTIV2018) organised by the European Society of Toxicology was held in Berlin this October 2018.  This year marks its 20th meeting, with the general theme of new approach methodologies